Physicians' Academy for Cardiovascular Education

Atrial fibrillation

Smartphone-based AF screening in the general population

5' education - Oct. 28, 2019 - Paris, France - Tine Proesmans

Clear results with NOAC monotherapy in patients with CAD and AF

3' education - Sep. 2, 2019 - Prof. Freek Verheugt

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

Proof-of-concept study shows 84% true AF in those with irregular pulse detected with smartwatch

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Michael Valentine, MD

Population screening for atrial fibrillation with a smartphone

10' education - Aug. 26, 2018 - Munich, Germany - Prof. dr. Pieter Vandervoort - Genk, Belgium

Atrial fibrillation & HFpEF: Novel device and therapeutic approaches

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Dipak Kotecha - Birmingham, UK - Online CME

Considerations on antithrombotic treatment of VTE and AF patients

10' education - Mar. 8, 2018 - Prof. Menno Huisman and dr. Alexander Cohen

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.

Initiating digoxin in AF patients associated with early hazard of sudden death

3' education - Mar. 19, 2017 - ACC 2017, Washington, DC, USA - Dr. Renato Lopes

Tailoring oral anticoagulation in elderly patients with AF

3' education - Nov. 12, 2016 - New Orleans, LA, USA - Christopher B. Granger, MD (Durham, NC, USA)

Outstanding questions and ongoing studies on the use of NOACs

3' education - Oct. 7, 2016 - Berg en Dal, The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA)

Oral anticoagulation in daily clinical practice in varous patient populations

10' education - Oct. 6, 2016 - The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA) and Marc Brouwer, MD (Nijmegen, The Netherlands)

Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation

3' education - Apr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Christian T. Ruff, MD - Boston, MA, USA
##SCROLLER_ITEMS_FULL_TITLE##

Where are we with HF patients with AF?

3' education - Oct. 31, 2015 - HF Summit, Barcelona, Spain - Dr. Dipak Kotecha
##SCROLLER_ITEMS_FULL_TITLE##

Translating new clinical trial data of DOACs for stroke prevention into clinical practice

3' education - Mar. 30, 2014 - VBWG at ACC - Michael Ezekowitz MD, PhD

Rate, trends and predictors of early mortality after AF ablation

Literature - Nov. 7, 2019 - Cheng EP, et al. - J Am Coll Cardiol 2019

In a real-world cohort including data of >60,000 AF ablation procedures performed between 2010-2015, early mortality rate was 0.46%. Strongest predictors for early mortality were procedural complications, CHF and low AF ablation hospital volume.

Lower risk of osteoporotic fractures in AF patients with DOAC vs. VKA treatment

Literature - Oct. 29, 2019 - Binding C, et al. - J Am Coll Cardiol 2019

In a Danish cohort study of nonvalvular AF patients, DOAC use was associated with a lower risk of osteoporotic fractures compared to VKA treatment.

Smartphone-based AF screening in the general population

5' education - Oct. 28, 2019 - Paris, France - Tine Proesmans
Tine Proesmans explains how screening for AF can be done in the general population using a smartphone and shares results of the DIGITAL-AF II study.

CSI Paris Tine Proesmans explains how screening for AF can be done in the general population using a smartphone and shares results of the DIGITAL-AF II study.

Ischemic outcomes with antithrombotic regimes in AF patients with ACS or undergoing PCI

Literature - Oct. 14, 2019 - Potpara TS, et al. - Europace 2019

A meta-analysis of RE-DUAL PCI, PIONEER AF-PCI and AUGUSTUS compared NOAC- and VKA-based regimens and antithrombotic therapies with and without aspirin for ischemic outcomes and CV and total mortality.

Parental smoking increases AF risk in offspring

Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019

Data of the Framingham Original and Offspring Cohorts show that parental smoking during childhood is associated with a higher AF risk, partly because offspring show higher propensity of smoking.

Long-term obesity and BMI change associated with increased risk for AF

Literature - Sep. 24, 2019 - Feng T et al., - Eur Heart J. 2019

Large community-based study with repeated weight and height measurements shows that long-term obesity and change in BMI over time are more informative to assess AF risk than current weight.

Clear results with NOAC monotherapy in patients with CAD and AF

3' education - Sep. 2, 2019 - Prof. Freek Verheugt
Prof. Verheugt talks about the results of the AFIRE trial, in which monotherapy with rivaroxaban was compared with a combination therapy of rivaroxaban and antiplatelet agents in CAD patients with AF.

ESC 2019 Prof. Verheugt talks about the results of the AFIRE trial, in which monotherapy with rivaroxaban was compared with a combination therapy of rivaroxaban and antiplatelet agents in CAD patients with AF.

Artificial intelligence helps pick up AF in ECG acquired during normal sinus rhythm

Literature - Aug. 14, 2019 - Attia Z et al., - The Lancet 2019

An AI model permits point-of-care identification of individuals with a high likelihood of AF, in normal sinus rhythm ECGs, based on subtle findings due to structural changes in the atria.

Factor Xa inhibitor effective and safe in AF patients with liver disease

Literature - July 23, 2019 - Qamar A, et al. - J Am Coll Cardiol 2019
In a subanalysis of the ENGAGE AF-TIMI 48 study, efficacy and safety of high dose edoxaban was similar in AF patients with and without liver disease.

In a subanalysis of the ENGAGE AF-TIMI 48 study, efficacy and safety of high dose edoxaban was similar in AF patients with and without liver disease.

No reduction in mortality and CV outcomes with catheter ablation in AF

Literature - Apr. 2, 2019 - Packer DL, et al. - JAMA 2019

In the CABANA trial, catheter ablation did not result in a reduction of death, disabling stroke, serious bleeding or cardiac arrest in symptomatic AF patients compared to drug therapy.

Delayed cardioversion non-inferior to early cardioversion in recent-onset AF

Literature - Apr. 2, 2019 - Pluymaekers NAHA et al. - New Eng J Med 2019
A wait-and-see strategy with rate-control drugs was non-inferior to early pharmacologic or electric conversion in achieving sinus rhythm among patients with recent-onset symptomatic AF.

A wait-and-see strategy with rate-control drugs was non-inferior to early pharmacologic or electric conversion in achieving sinus rhythm among patients with recent-onset symptomatic AF.

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD
Dr. John Alexander summarizes the main findings of the AUGUSTUS trial, in which apixaban yielded better results than warfarin, and those not on aspirin did better than those taking aspirin, in patients with AF and a recent ACS/PCI.

ACC 2019 Dr. John Alexander summarizes the main findings of the AUGUSTUS trial, in which apixaban yielded better results than warfarin, and those not on aspirin did better than those taking aspirin, in patients with AF and a recent ACS/PCI.